Evaluation of the Effectiveness of Risk Minimisation Measures: A Survey among Health Care Professionals to Assess their Knowledge on Dosing and Administration of ObizurĀ® (Susoctocog alfa) in 6 European Countries

23/05/2019
04/08/2022
EU PAS number:
EUPAS29813
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information